This is the main problem with this discussion. People misconstrue what I am saying even though I have repeated it several times.
This seems to happen a lot in the forums. I would assume that most people are not deliberately twisting your words, or trying to set up strawmen. Perhaps if you feel you're being misconstrued you can restate your position?
1) There IS evidence that shows ECG screening in athletes IS a HELPFUL screening tool and HAS been shown to reduce deaths. I AM WELL AWARE THIS IS NOT CONCLUSIVE EVIDENCE - see #2.
I don't think anyone is arguing that ECG screening can identify patients at risk for hypertrophic cardiomyopathy or ARVD, LQTS, etc. I think that's common ground.
I think we also have a general consensus that the ECG is not a particularly sensitive or specific means of evaluating hypertrophy. But that it is much more pratical than echocardiography.
However, several studies do support screening programs and these programs ALREADY exist with GOOD results - several students ended up on medication and several were identified as needing surgery as a result of this routine screening.
I'm not sure that you've adequately supported this statement. One paper you linked [1] evaluated 1,424 students, found ECG changes worthy of restricting activity in 12 patients, who were then subsequently cleared to return to exercise following echo.
It's probably likely that these patients may receive further follow up testing, and be aware of the potential for future problems to develop. If followed up long enough, it's possible that one of these students might have a syncopal episode, that someone might attribute to electrocardiographic abnormalities identified in this study. It might be beneficial in this instance. But this study failed to demonstrate a benefit.
The second study you presented [2] uses the Italian data, and attempts to extrapolate it to the US population and present a model of the theoretical economic benefits. It's not without merit -- but it's not a report of an existing screening program. It could be used to make inferences about the likely cost or benefit of such a program once it was introduced in the US, but this is still quite aleap.
2) There is NO evidence that say's ABSOLUTELY without a doubt that ECG screening is not useful and life saving. Evidence exists that says screenings make no difference or more so, makes so little difference that cost is not warranted.
And that seems to be the issue here. Is whether it's worth the cost. The study that attempts to address this, is available free here, for anyone who wants to read it:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873148/?tool=pubmed
At $89/test, with 25 million student athletes, it could become very costly.
They're projecting a cost of $21,200-71,300/ year of useful life saved, and assuming a post-testing life expectancy of 60 years for all identified patients (which may not be a valid assumption). If we define a "life saved", it looks to me like there's a cost of $1.2-4.2 million / life saved. But that might not be a valid inference from the text.
3) It HAS been found that the logistics that many people cite as a roadblock can be overcome and these screenings can be cost effective - including the ECG, echo, and follow-up care.
I don't think that the data you've presented supports that statement. They've reported cost-effectiveness numbers, but whether this intervention can be considered cost-effective probably depends on what other avenues for healthcare dollars are available and the relative merits of increasing funding in those areas.
4) I am well aware of the limitations of 12-lead screening. I know they will not catch everything. I am well aware some students will still slip through. I am well aware a 12-lead will NOT end student athlete deaths but it CAN identify some at risk and save lives.
I don't think this is being disputed, is it?
What I don't think is being discussed enough is the burden of a false-positive. The ECG and echocardiogram themselves are pretty benign. But what's the cost to the student athlete who's told they can't compete until follow-up has been performed, and loses a half-season, or a place on a team? What's the dollar value of having some sort of minor-normal variant identified on your ECG and spending the rest of your life worrying about your CVD risk?
I appreciate these things are hard to quantify, but they're worth mentioning.
5) Based on current data, research, and cardiologists opinion, it is NOT unreasonable for a person to be willing to further explore these programs and support their implementation in their own community until more conclusive data says otherwise.
I'm not sure I agree with this either. Is it worth introducing this if the benefit is small, and the cost high?
I mean, I don't mind paying taxes. I'm pretty left wing. I like supporting the health care system. I think it's fantastic. But I'm not convinced that this is the best area for my tax dollars to be spent in.
It might be interesting to see some sort of study performed to compare a screening program with ECG to a screening program without. But this might also be very expensive.
To make a (non-evidence based, and completely anecdotal) EMS comparison -- if I have a patient who's overdosed on INH, I'd love to have a bucket load of pyridoxine (B6) on the ambulance. It would be potentially life-saving. But I've seen this once. The crew that had the patient gave massive amounts of benzodiazepine and ran to the first ER we could find that actually had pyridoxine on hand. I can motivate the cost of putting the B6 on the trucks by the potential that it might save lives, but if we throw it out every couple of months, and the system sees this sort of call every couple of years, is it going to be worth it?
I know in my area, the local hospital has an annual health fair where they offer free diagnostic testing at the local high school. They offer free ECG's, echo's, and lab work. Why is that? Because benefit does exist in routine diagnostic testing and it's important to establish a baseline to identify changes later on in life. These tests are performed as an endeavor to improve community health.
Are they trying to improve community health? Or is it an attempt to advertise service and provide PR? Educate the students about health? Promote health care careers?
If the benefit is there, why hasn't it been shown in the peer-reviewed literature? And if it has, why not link to it here?
But according to you all, the hospital should have big studies to justify the testing performed at the health fair.
I know this isn't directed at me personally, but yes. They should.
If we're going to spend finite resources doing something, we should demonstrate that what we are doing is worthwhile. Otherwise we should direct those finite resources elsewhere.
Without a study its just a waste of time to try to make a difference, right?
No. It's not a waste of time to try and make a difference. But we might be wasting our time because we're not making a difference. There's an important distinction there.
Why waste time screening people in the community with an echo who are asymptomatic, right? The thought of picking up on something insidious is like finding a million dollars tonight, right?
Well, this is the question? Are we spending 10 million dollars that could be spent in an area where there's demonstrable benefit to save a million dollars elsewhere?
Just because a patient is not symptomatic or rise to the level of suspicion for a physician to order a test, doesn't mean a problem isn't in the making.
I don't think anyone is arguing against this point.
Continue to think what you want. It's cool. I'm not going to criticize anyone for it. It's very reasonable to be against the 12-lead testing at this point in time. I see both sides. I just choose to err on the side of benefit and saving lives even if that is only 50 a year.
You're entitled to your opinion. Just as other people are entitled to disagree with you.
But at the same time, if you can't justify that opinion in the basis of peer-reviewed research, you are going to have difficulty convincing people with an academic background to side with you.
It's been fun discussing this, though. I hope there's no hard feelings.
[1]Lacorte MA, Boxer RA, Gottesfeld IB, Singh S, Strong M, Mandell L. EKG Screening Program for School Athletes Clin. Cardiol. 12, 42-44 (1989)
[2]Wheeler MT, Heidenreich PA, Froelicher VF, Hlatky MA, Ashley EA.
Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes. Ann Intern Med. 2010 Mar 2;152(5):276-86.